Compass Therapeutics LLC

Amendment

CIK: 0001610824·Biotechnology·DELAWARE·Filed: May 28, 2015

Total Offering

$1,000,000

Amount Sold

$575,000

Investors

4

First Sale

May 30, 2014

Offering Details

Type: Debt
Exemptions: Rule 506(b)
Entity Type: Limited Liability Company
Year Incorporated: 2014
Non-Accredited Investors: No

Related Persons

Name	Role
Errik Anderson	Related Person
Schuetz Thomas	Related Person
Steve Tregay	Related Person

Company

Compass Therapeutics LLC

44 SOUTH MAIN STREET

HANOVER, NH, 03755

617-500-8099

SEC Filing

0001610824-15-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.